Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

BACKGROUND: Vedolizumab is safe and effective in adult patients with Crohn’s disease (CD) and ulcerative colitis (UC); however, data in children with inflammatory bowel disease (IBD) are scarce. Therefore, we evaluated vedolizumab use in a cohort of Austrian paediatric patients with IBD. METHODS: Tw...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Gastroenterol
Egile Nagusiak: Schneider, Anna-Maria, Weghuber, Daniel, Hetzer, Benjamin, Entenmann, Andreas, Müller, Thomas, Zimmermann, Georg, Schütz, Sebastian, Huber, Wolf-Dietrich, Pichler, Judith
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139155/
https://ncbi.nlm.nih.gov/pubmed/30219028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-018-0868-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak